Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hepa/Biliary Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hepa/Biliary Other
    Changes Not Affecting Tumour Size May Better Predict Outcomes to Bevacizumab: Presented at RSNA - (DGDispatch)
    Adding Cetuximab to Chemotherapy Increases Tumour Shrinkage In Advanced Colorectal Cancer - (DGNews)
    New Drug Regimen Shows Promising Results for Advanced Biliary-Tract Cancers - (DGNews)
    Statin use and risk of gallstone disease followed by cholecystectomy - (JAMA)
    What Is the Optimal Timing of Hepatitis C Antiviral Therapy Before and After Liver Transplantation? Presented at AASLD - (DGDispatch)

    News archive

     Recent webcasts/CME - Hepa/Biliary Other
    • Active Ulcerative Colitis: Selection of First-Line Therapies for Better Patient Outcomes
    • Alpha1-Antitrypsin Augmentation: Approaches and Benefits
      Drug-Induced Liver Disease, Part 2
      Drug-Induced Liver Disease, Part 1
      The Meso-Rex Bypass for Portal Hypertension in Children

      Webcasts/CME archive

       Recent cases - Hepa/Biliary Other
        Acute Cholangitis Due To Pancreatic Metastasis From Squamous Cell Lung Carcinoma: A Case Report And Review Of Literature
        A Latent Form Of Essential Thrombocythemia Presenting As Portal Cavernoma
        Liver Abscess And Sepsis With Bacillus Pantothenticus In An Immunocompetent Patient: A First Case Report
        Abscess of the Round Ligament of the Liver Associated with Acute Obstructive Cholangitis and Septic Thrombosis
        An Atypical Case of Hepatic Cavernous Hemangioma: A Case Report

        Cases archive
          




        my personal edition > hepa/biliary other > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Left Side Grafting Has Lower Risk Than Right Lobe in Living Donor Liver Transplantation

          HOBOKEN, NJ -- October 29, 2009 -- A study published in the November issue of Liver Transplantation shows that left side grafting has lower risk to donors compared with grafts taken from the right lobe, and it appears to be the procedure of choice for adult-to-adult living donor liver transplantation (LDLT).

          Researchers also found that graft size was not the only cause behind small-for-size graft syndrome, a severe complication resulting in organ malfunction and transplant failure.

          For the study, Toshihiko Ikegami, MD, Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, and colleagues performed LDLTs on 120 adult patients through October 2007.

          Patients were divided into 2 groups: group S consisted of 33 patients who received liver grafts < 35% of their standard liver volume (SLV), and group L consisted of 87 patients who received liver grafts >= 35% of their SLV.

          Results showed the 1- and 5-year survival rates in group S were 80.7% and 64.2% respectively; and in group L 90.8% and 84.9%, with no significant difference between groups.

          Between 1 and 5 years after LDLT, 7 patients died with causes of death including cerebral infarction, recurrence of liver cancer, uterine cancer, and sepsis. ôThese deaths occurred in patients with good liver function who had resumed their normal lives,ö commented Dr. Ikegami. ôThe causes of death were not related to insufficient graft size.ö

          Past studies have recommended a graft volume to recipient standard liver volume (GV/SLV) ratio of >40% and a graft-to-recipient weight ratio (GRWR) of >= 0.8% to achieve good graft and recipient survival rates.

          In the current study patients in group S had a good survival rate, despite a GV/SLV ratio below 35% and a GRWR not exceeding 0.8%. Dr. Ikegami points out, ôOur research shows small graft size does not appear to be the only cause of small-for-size graft syndrome. The prognosis of recipients with liver grafts < 35% of their SLV is comparable to that of recipients with larger grafts.ö

          According to the U.S. Department of Health and Human Services, 3,549 deceased donor and 249 LDLTs (5%) were performed in 2008. In Japan, 99% of all liver transplantations use living donors. The authors speculate that the lower percentage of LDLTs in the U.S. could be attributed to a highly publicised donor death in 2002 and that it is conceivable that the next donor death in Japan could lead to a similar resistance in that country. ôWe feel that left side grafts should be used more frequently in adult-to-adult LDLT, considering the lower risk to donors compared to right lobe grafts,ö recommended Dr. Ikegami.


          SOURCE: Wiley Blackwell




        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send